The Egyptian Journal of Chest Diseases and Tuberculosis 2020, 69:33-38 of PTB and RIF resistance; moreover, watery sputum and acid-fast bacilli smear positive cases are powerful predictors of Xpert MTB/RIF detection.
Background
GeneXpert Mycobacterial tuberculosis (MTB)/rifampicin (RIF) is a standard primary test for early diagnosis of pulmonary tuberculosis (PTB) and RIF resistance. The GeneXpert technique provides a useful tool for tuberculosis control in endemic areas. Objective To assess the diagnostic performance of GeneXpert and rule out the independent risk factors that influence the outcomes.
Patients and methods
In all, 452 presumed PTB patients were enrolled in this prospective study. Three consecutives morning sputum samples underwent decontamination and liquefaction. Smear microscope, conventional solid culture media (Lowenstein-Jensen media as reference standards), and GeneXpert were performed in sputum specimens. Results A total of 452 test results uploaded from GeneXpert machine 112/452 (24.7%) showed MTB detection and RIF resistance detected in 9/112 (8%). GeneXpert had a sensitivity of 91.1% and a specificity of 100%, with total accuracy of 97.31%. The percentage of GeneXpert positive outcomes in watery phlegm was highly significant in comparison to mucoid phlegm (odds ratio: 61.30; 95% confidence interval: 14.653-88.01; P<0.01); also GeneXpert MTB detection was significantly higher in sputum smear positive than negative cases (odds ratio: 14.474; 95% confidence interval: 0.086-0.456; P<0.01). Conclusion GeneXpert MTB/RIF is a useful qualitative and quantitative test for early detection Introduction Early diagnosis of pulmonary tuberculosis (PTB) is the cornerstone in minimizing global incidence and spread of tuberculosis (TB) infection [1] . Conventional diagnostic methods for Mycobacterial tuberculosis (MTB) are slow and/or lack sensitivity [2] . Several techniques have been used for the diagnosis of PTB, that is, smear microscopic examination, Mantoux test, culture test (both manual and automated), histological/ cytological examination, serological assays (both antigen and antibody detection), and PCR assays (conventional as well as real-time PCR) [3] .
Xpert MTB/rifampicin (RIF) is real-time PCR for molecular diagnosis of TB and RIF susceptibility test [4] . The outcomes of Xpert had been achievable within 2-h duration. It provided quantitative and qualitative results according to bacillary burden in sputum specimens, which was inversely proportional with cyclic threshold [5] . The Xpert technique had higher diagnostic yield in smear negative as well as multidrug resistance or extended drug resistance PTB cases due to its unique ability to discover rpoB gene mutation [6] . On the other hand, conventional solid culture media for PTB consumed up to 6 weeks for MTB growth and further 3 weeks for drug susceptibility test (DST). Lack of TB control was a consequence of long duration that had been consumed via conventional diagnostic methods [7] . The key performance indicators of GeneXpert in early diagnosis of PTB and RIF resistance could be analyzed into multiple factors, first related to personnel (doctors and technicians) regarding sample collection, its quality and nature as well as sample processing, handling of Xpert machine and data interpretation. Second, related to Xpert machine: environmental factors such as room temperature, humidity, electricity, maintenance, operating system, and loading cartilage validity were essential for proper Xpert performance. Furthermore, third pivotal factors related to suspected PTB cases: their demographic data (age and sex) and smoking. Bacillary burdens (smear negative or positive) and whether suspected PTB cases had been treated before with anti-TB treatments (retreatment cases) or fresh new cases [8] . Therefore, we sought to determine the diagnostic performance of Xpert in presumed pulmonary TB patients and RIF resistance and ruling out the independent risk factors that influence the outcomes [7] . The priority of Xpert MTB/RIF as a diagnostic method of PTB was related to its suitability and feasibility as quick, reliable, controllable, effortless, timed, and economic test [7] .

Study population
Overall 452 cases with presumptive pulmonary TB were assessed for eligibility to enter the study between December 2016 and January 2019 in Chest Hospital; 112 (Xpert positive cases) were enrolled in this prospective cohort study. Demographic data, pervious anti-TB treatment history, and chest roentgenography (radiograph or CT if needed) results were recorded at enrollment; phlegm specimens were gathered from patients with presumed TB. And each participant gave at least three sputum specimens on 2 separate days. If patients cannot expectorate the sputum, ultrasonic nebulizer technique was used for sputum induction. Xpert diagnostic yield was compared with culture tests and DST as reference standards in same sputum specimen. Pretreated cases with anti-TB treatments (>2 weeks within last 2 months) were excluded. This study was approved by Health Sciences Ethics Committee.
Laboratory analysis
Microbiologic testing followed the standard protocols. All phlegm specimens were subjected to the following: I. Ziehl-Neelsen staining by smear microscopy, smears were repeated on next 2 days [1] . II. Culture on Lowenstein-Jensen (LJ) media: after liquefaction decontamination technique, sputum samples were cultured on LJ media slopes of less than 37°C.
Culture was not considered negative except after 8 weeks. Sputum culture was considered the gold standard technique in this study. III. GeneXpert MTB/RIF PCR test (Cepheid, Sunnyvale, California, USA): according to manufacturer's instruction [8] . Data interpretation was received after completion of the PCR run through computed software [9] .
Statistical analysis
The data were collected, tabulated, and analyzed by statistical package for the social sciences (SPSS) version 17.0 on IBM compatible computer (SPSS Inc., Chicago, Illinois, USA). Qualitative data were described as frequency and percentage and compared using χ 2 testing while the quantitative ones were presented as mean±SD and compared using Student's t-test (Tables 1-7) .
Results
A prospective cohort study was designed to assess the validity of GeneXpert in TB diagnosis as well as RIF resistance, and compared GeneXpert MTB/RIF with conventional LJ media as the gold standard of diagnosis of PTB.
Sputum smear microscopic examination, solid culture cultivation, and Xpert investigation were consequently done for proper PTB diagnosis.
Overall, a total of 452 test results uploaded from Xpert machine 112/452 (24.7%) showed MTB detection and RIF resistance detected in 9/112 (8%). Of the total number of tests conducted 6.8% were invalid, 2.4% had error results, 2.2% had culture contamination, and 61.2% had negative Xpert; however 2.4% (false negative) showed growth in LJ media with negative Xpert results. Flow chart is illustrated in (Figure 1) .
A total 112 of Xpert positive patients were assigned into two groups according to the sputum acid-fast bacilli (AFB) smear into positive (n=54) and negative (n=58) groups. Sex, smoking, Xpert MTB detected (bacterial load), and Xpert MTB-RIF resistance were significantly higher in smear positive than negative group.
Sex (male), smoking, retreatment, sample type (sputum), sputum nature (watery), positive AFB smear, bacterial load, and RIF resistance overall were the risk factors associated with Xpert MTB detection.
Logistic regression analysis of different variables moreover analyzed the risk factors that influence Xpert positivity; the percentage of Xpert positive outcome in salivary sputum was highly significant than mucoid phlegm (odds ratio: 61.30; 95% confidence interval: 14.653-88.01; P<0.01). Also Xpert MTB detection was significantly higher in sputum smear positive than negative cases (odds ratio: 14.47; 95% confidence interval: 0.086-0.456; P<0.01).
Xpert had a sensitivity of 91.1%, and specificity of 100%, with total accuracy of 97.31%. There was significant positive correlation between Xpert MTB detection and AFB smear results (bacterial load). Also, significant positive correlation was recorded between RIF's resistance and treatment history.
Discussion
Persistent rising in universal prevalence of MTB has necessitated rapid diagnostic techniques [2, 5] . Conventional diagnostic methods for MTB are slow and/or lack sensitivity [2, 5] . Real-time PCR played a pivotal role in TB diagnosis [1, 6] GeneXpert MTB/ RIF assay is an automated, closed-cartridge system, and is easy to operate [2] . It supplys a quick and specific technique of early diagnosis of PTB in endemic, developing countries [1, 4] .
This study is targeted to validate the role of Xpert in early diagnosis of PTB and also to rule out the independent risk factors that influence Xpert MTB/ RIF detection and weather there are correlations between Xpert MTB/RIF detection with RIF's resistance and other independent variables.
Our data has shown that of the total number of tests conducted 6.8% were invalid, 2.4% had error results, 2.2% had culture contamination, and 61.2% had negative Xpert; however 2.4% (false negative) showed growth in LJ media with negative Xpert results. [11] reported that the nature of collected sputum sample and its quality, sputum processing, technical errors, and lack of training courses as well as Xpert machine maintenance, faulty modules and expired cartilage are all offending agents that could influence Xpert performance.
In this study, Xpert had a sensitivity of 91.1% and specificity of 100%, with a total accuracy of 97.31%. Our data has shown that sex (male), smoking, sample type (sputum), sputum nature (watery), positive AFB smear, and bacterial load were the risk factors associated with Xpert MTB detection.
A previous study declared that Xpert sensitivity of the smear positive specimens has been cited from 98 to 100% and smear negative specimens were found to be sensitive from 74.2 to 77.7% [11] .
Several works have shown that validity of GeneXpert RIF's resistance test for TB identification were 98 and 67% in sputum smear positive and negative, respectively, while specificity was 99%. However, RIF resistance test declared 95 and 98% sensitivity and specificity, respectively [12] .
In a prospective, multicenter, diagnostic accuracy study in 2016 Susan and her colleague [3] reported sensitivities of GeneXpert to be 99 and 46%, for sputum smear positive and negative, respectively.
Blood, cerebrospinal fluid (CSF), and urine samples had lower bacillary burdens; the diagnostic efficacy has not been determined and are quite variables in different Patients participated in this study.
Observational cross-sectional study determined the sensitivity and specificity of Xpert technique; it was 92.4% (86/93) and 97.1% (138/142), respectively. The sensitivity was 98.4% (60/61) in culture-proven smear positive samples, while sensitivity in culture-proven smear negative samples was 93.7% (30/32), using culture as the reference standard.
Explanation: The reported minute difference in sensitivity related to the number of sputum samples per subjects, one specimen was collected, while others and in this study had collected three specimens. Also, they used pellets of the decontaminated samples instead of direct expectorated sputum as our procedure in this study. Furthermore, this study used only sputum while other studies include all possible pulmonary samples [13] .
Sajjad et al. [2] demonstrated seven cases which were positive on culture and negative on Xpert MTB/RIF assay among smear negative specimens. This contradiction could be justifiable via the difference in the detection of analytical limit; the culture can detect as low as 10-100 CFU/ml, while MTB/RIF assay detect 131 CFU/ml [10] .
Meyer and colleagues declared that the sputum nature affects MTB/RIF performance on a wide scale ranging from highest sensitivity in watery sputum, intermediate in mucoid, and lowest in blood-tinged sputum, while specificity was nearly the same.
Sputum nature necessarily has an association with the existence of MTB in sputum tested with Xpert [9, 11] . However, small studies had clarified that watery sample could be unfeasible for Xpert examination [13] .
Possible justification could be a higher MTB load of DNA in watery sputum [13] .
In contrast, blood-stained sputum was unlikely suitable for Xpert testing. A potential causation may be due to the potential ability of blood to inhibit DNA amplification [12] .
The likelihood of negative Xpert was higher in retreated patients as previous anti-TB treatments minimized the bacillary burdens and the validity of MTB in sputum specimen [14] .
Conclusion
XpertMTB/RIFisachallengingtestforearlydiagnosisof PTB. The Xpert technique should be implemented in the diagnostic algorithm of PTB added to clinical, radiological, and microbiological investigation and it does not replace them. Successful performance of GeneXpert could be achievable with further assessment of different variables related to logistic preparation, welltrained investigators, and patients' populations.
Limitations
Our study is of insufficient size analysis. Implementation of solid rather than liquid culture media, as well as high rate (10%) of contamination in solid culture, and lack of DST (as a reference standard for RIF resistance) are overall limitations of this research.
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